You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immediate Release Niacin,

Showing 1 - 25 of 9,558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Oct 5, 2023

Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)

Not yet recruiting
  • Healthy Volunteers
  • BMS-986419 DR Capsule
  • BMS-986419 IR Tablet
  • (no location specified)
Jul 20, 2023

Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)

Active, not recruiting
  • Atopic Dermatitis
  • TLL-018 extended-release tablet
  • TLL-018 immediate-release tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023

Healthy Participants Trial in Ruddington (ALXN2050 MR Prototype Tablet, ALXN2050 Immediate Release (IR) Tablet, ALXN2050 MR

Not yet recruiting
  • Healthy Participants
  • ALXN2050 MR Prototype Tablet
  • +2 more
  • Ruddington, Nottinghamshire, United Kingdom
    Quotient Science Ltd
Mar 13, 2023

Flat Foot Trial in Istanbul (Graston, Percussive massage)

Completed
  • Flat Foot
  • Graston
  • Percussive massage
  • Istanbul, Turkey
    İstanbul Gelisim University
Sep 14, 2023

Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

Recruiting
  • Migraine Prophylaxis
  • Nicotinic Acid 500 MG Extended Release Oral Tablet
  • +2 more
  • Dhaka, Bangladesh
    BSMMU
May 5, 2023

Healthy Trial in Porto (Dynamic foam rolling)

Recruiting
  • Healthy
  • Dynamic foam rolling
  • Porto, Portugal
  • +1 more
Feb 10, 2023

N/A Healthy Individuals Trial (Myofascial Release, Light Touch Contact)

Not yet recruiting
  • N/A Healthy Individuals
  • Myofascial Release
  • Light Touch Contact
  • (no location specified)
Jun 21, 2023

Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg

Not yet recruiting
  • Healthy Participants
  • Treatment A: Emraclidine 30mg IR tablets (reference)
  • +3 more
  • Overland Park, Kansas
    Overland Park, Kansas
Jun 28, 2023

Tension-Type Headache Trial in Rawalpindi (sustained natural apophyseal glides (SNAGS), suboccipital muscle release,

Active, not recruiting
  • Tension-Type Headache
  • sustained natural apophyseal glides (SNAGS)
  • +2 more
  • Rawalpindi, Punjab, Pakistan
    Fauji Foundation Hospital
May 22, 2023

Myofascial Spasm Trial in Istanbul (Self myofascial Release, myofascial release)

Not yet recruiting
  • Myofascial Spasm
  • Self myofascial Release
  • myofascial release
  • Istanbul, Maltepe, Turkey
  • +2 more
Apr 6, 2023

Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)

Completed
  • Abuse Potential
  • Placebo
  • +4 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas
Oct 19, 2023

Healthy Volunteer Trial in Grayslake (ABBV-903 Tablet Form 1, ABBV-903 Tablet Form 2)

Recruiting
  • Healthy Volunteer
  • ABBV-903 Tablet Form 1
  • ABBV-903 Tablet Form 2
  • Grayslake, Illinois
    Acpru /Id# 254926
Apr 20, 2023

Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

Active, not recruiting
  • Neuropathic Pain
  • Diabetes Mellitus, Type 2
  • pregabalin sustained release tablet
  • pregabalin immediate release capsule
  • Cheongju, Chungcheongbuk-do, Korea, Republic of
  • +7 more
Nov 14, 2022

Hamstring Injury, Masseter, Myofascial Release Trial in Ankara (Static stretching, Myofascial Release)

Recruiting
  • Hamstring Injury
  • +5 more
  • Static stretching
  • Myofascial Release
  • Ankara, Keçiören, Turkey
    Caglar Soylu
Jan 26, 2023

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

Hyperactivity in Children With Down Syndrome, Impulsivity in Children With Down Syndrome Trial (Guanfacine Hydrochloride

Not yet recruiting
  • Hyperactivity in Children With Down Syndrome
  • Impulsivity in Children With Down Syndrome
  • Guanfacine Hydrochloride Immediate Release
  • Placebo
  • (no location specified)
Sep 18, 2023

Safety Issues, Pharmacokinetic Trial in Kiel (controlled-ileocolonic-release nicotinamide (SAD/MAD/MD), Immediate-release

Recruiting
  • Safety Issues
  • Pharmacokinetic
  • controlled-ileocolonic-release nicotinamide (SAD/MAD/MD)
  • +3 more
  • Kiel, Germany
    University Medical Center Schleswig-Holstein
Feb 16, 2022

Recreational Drug Use Trial in Columbus (PF614, Oxycodone, Placebo)

Completed
  • Recreational Drug Use
  • Columbus, Ohio
    Ohio Clinical Trails
Dec 23, 2022

Lateral Epicondylitis Trial in Lahore (mulligan mobilization, myofascial release)

Completed
  • Lateral Epicondylitis
  • mulligan mobilization
  • myofascial release
  • Lahore, Punjab, Pakistan
    Sumra Riaz
Oct 1, 2022

Healthy Trial (Dexamethasone, Chronocort: fasted, Immediate release hydrocortisone: fasted)

Completed
Has Results
  • Healthy
  • (no location specified)
Apr 5, 2022

Recreational Drug Use Trial in Overland Park (PF614, Oxycodone Hydrochloride 40 mg, Placebo)

Completed
  • Recreational Drug Use
  • Overland Park, Kansas
    Dr. Vince Clinical Research
Jan 3, 2023

Chronic Rhinosinusitis (Diagnosis) Trial (Budesonide, Mucosal Atomization Device, NeilMed squeeze bottle for Impregnated Nasal

Withdrawn
  • Chronic Rhinosinusitis (Diagnosis)
  • (no location specified)
Jul 7, 2022

Hypercholesterolemia, Hyperlipidemia Trial (Vytorin + Niaspan, Vytorin, Niaspan)

Completed
  • Hypercholesterolemia
  • Hyperlipidemia
  • Vytorin + Niaspan
  • +2 more
  • (no location specified)
Feb 7, 2022

Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)

Recruiting
  • Healthy
  • BLU-5937 IR
  • BLU-5937 ER
  • Nottingham, England, United Kingdom
    Quotient Sciences
Oct 4, 2022